Golden State Wealth Management LLC Makes New Investment in Utah Medical Products, Inc. (NASDAQ:UTMD)

Golden State Wealth Management LLC bought a new stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 500 shares of the medical instruments supplier’s stock, valued at approximately $31,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC raised its stake in Utah Medical Products by 128.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after acquiring an additional 50,030 shares during the period. Minerva Advisors LLC grew its holdings in shares of Utah Medical Products by 461.8% during the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock valued at $2,818,000 after purchasing an additional 34,794 shares during the last quarter. Rice Hall James & Associates LLC raised its position in shares of Utah Medical Products by 24.3% during the 3rd quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier’s stock worth $5,576,000 after purchasing an additional 16,297 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of Utah Medical Products by 439.0% in the 3rd quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier’s stock worth $964,000 after purchasing an additional 11,735 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Utah Medical Products by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock worth $6,497,000 after purchasing an additional 8,516 shares during the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Stock Up 1.0 %

UTMD stock opened at $61.04 on Wednesday. The firm’s 50-day simple moving average is $61.94 and its 200 day simple moving average is $64.85. The stock has a market cap of $206.93 million, a PE ratio of 15.45 and a beta of 0.08. Utah Medical Products, Inc. has a fifty-two week low of $58.87 and a fifty-two week high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be paid a $0.305 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.22 annualized dividend and a dividend yield of 2.00%. Utah Medical Products’s payout ratio is 30.89%.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.